Alembic Pharmaceuticals’ Q1 consolidated net profit registers 45% growth

29 Jul 2016 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2016.

The company has reported 53.22% rise in its net profit after tax at Rs 119.74 crore for the quarter ended June 30, 2016 as compared to Rs 78.15 crore for the same quarter in the previous year. The company’s total income increased by 20.01% to Rs 688.98 crore for the quarter under review from Rs 574.10 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 44.64% rise in its net profit after taxes and share of profit of associates at Rs 103.75 crore for the quarter ended June 30, 2016 as compared to Rs 71.73 crore for the same quarter in the previous year. Total Income of the company increased by 25.04% to Rs 728.42 crore for the quarter under review from Rs 582.57 crore for the same quarter ended June 30, 2015.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×